XOLAIR®


Powder for solution for injection, Solution for injection in pre-filled syringe
scheduling status
S4
registration number
A39/34/0311, 55/34/0713, 55/34/0714
What XOLAIR® contains
Omalizumab 150 mg (powder and solvent for solution for injection) Omalizumab 75 mg/0.5mL (pre-filled syringe) Omalizumab 150 mg/mL (pre-filled syringe).
other ingredients
Powder and solvent for solution for injection: Powder vial: Sucrose, histidine, histidine hydrochloride monohydrate, polysorbate 20 Solution for injection in pre-filled syringe: L-arginine hydrochloride, L-histidine hydrochloride, L-histidine, polysorbate 20, water for injection.
Therapeutic classification
R03DX05.
© 2026 SAHPRA. ALL RIGHTS RESERVED